Brief: Acer Therapeutics And Relief Therapeutics Announce Receipt Of Notice Of Allowance Of US Patent Application Covering A Kit Comprising Phenylbutyrate And Sodium Benzoate
Oct 3 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE RECEIPT
OF
NOTICE OF ALLOWANCE OF US PATENT APPLICATION COVERING A KIT
COMPRISING PHENYLBUTYRATE AND SODIUM BENZOATE
Source text for Eikon: ID:nGNX54pXFY
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on MindMaze Therapeutics Holding SA
See all newsBrief: Mindmaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
Brief: Relief Therapeutics Shareholders Approve Business Combination With Neurox
Brief: Relief Therapeutics Receives FDA Response To Qidp Request For Rlf-Td011
Brief: Relief Therapeutics Says Interim CEO Michelle Lock Has Completed Her Transitional Mandate
Swiss stocks - Factors to watch on May 13